Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Acupressure Instruments Market size was valued at USD 121.45 million in 2019 and is poised to grow from USD 131.45 million in 2023 to USD 247.47 million by 2031, growing at a CAGR of 8.23% in the forecast period (2024-2031). 

The majority of acupressure treatment and instrument providers are small market players, these players are using low-cost marketing strategies. Offering a free trial is one of the most popular ways to increase sales. With COVID-19 having a negative impact on the acupressure treatment and instrument market, market participants have now entered the telehealth domain. This not only helps organizations reach their customers but also helps them stand out in the market. A few Ed-tech companies also offer acupressure courses with a 30-day money-back guarantee. For instance, Udemy, a US-based ed-tech start-up offers "Acupressure For Beginners: Acupressure Principles". 'Johnson & Johnson (US) ', 'Medtronic plc (Ireland) ', 'Stryker Corporation (US) ', 'B. Braun Melsungen AG (Germany)', 'Abbott Laboratories (US)', 'Boston Scientific Corporation (US)', 'Smith & Nephew plc (UK)', 'Olympus Corporation (Japan)', 'Zimmer Biomet Holdings, Inc. (US)', 'Baxter International Inc. (US)', 'GE Health Care (US)', 'Philips Health Care (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Roche Diagnostics Limited (Switzerland)', '3M Company (US)', 'Cardinal Health, Inc. (US)', 'Terumo Corporation (Japan)', 'EssilorLuxottica (France)', 'Thermo Fisher Scientific Inc. (US)', 'Hologic, Inc. (US)'

The current treatment scenario for a variety of indications is the increased availability of alternative therapies, which include physiotherapy and complementary and alternative therapy. There is an array of side effects associated with the use of medications for the treatment of specific disease conditions, such as mental health indications or pain management in cancer patients. Adverse effects of medicinal drug intake are serious concerns for patient safety and may present with unpleasant symptoms ranging from drowsiness or extreme fatigue to impaired balance and coordination and low respiration rate, indicating a potential overdose. Because of the lack of associated complexities with drug interaction, the adoption of complementary medicines is expected to increase. This factor is expected to drive demand growth for Acupressure treatment over the forecasted years.

Allopathic medicine can be quite expensive in terms of the number of investigations required, as well as the expensive modern imaging techniques that allopathic practitioners require in almost all cases. As poverty rises to 9% by the end of 2021, many people will be forced to opt for less expensive alternative medicine, which acupuncture should benefit from. It is also worth noting that increased awareness is contributing to the growth of the acupuncture market over the forecast period.

North America held the largest share in the acupressure instruments market. North America currently leads the acupressure market due to increased acceptance of alternate solution medical techniques between many people and a rising incidence of chronic conditions. In 2021 alone, 20.4% of US citizens experienced chronic pain for a variety of reasons, and given the occurrence of unhealthy lifestyles, this figure is expected to rise. Because allopathic medicine has little to offer in these cases, the market should benefit.

Feedback From Our Clients

Global Acupressure Instruments Market

Product ID: SQMIG35A2223

$5,300
BUY NOW GET FREE SAMPLE